Online Store


Inject, Inhale…Choices for Taking Insulin

Member Price
Non-Member Price

  • Description
  • Faculty
  • Pricing
  • Credits

45-minute Program
Effective dates for CE credit: 4/1/2023 – 4/1/2024


This session was offered at the 2022 ADCES Diabetes Technology Conference. The speaker outlines the options available for taking insulin, explaining for whom different insulin options and regimens might best work. 

Learning Outcome

The diabetes care team will report an increased knowledge of insulin options and how to apply it uniquely to each client.

Activity Type

This recording of a live presentation is a knowledge-based learning activity.

Learning Format

Enduring Material

Intended Audience

This activity is designed for individual or groups of diabetes care and education specialists, including nurses, dietitians, dietetic technicians, pharmacists, pharmacy technicians, nurse practitioners, clinical nurse specialists, physicians, PAs, social workers, and other health care providers interested in staying up to date on current practices of care for people with diabetes and other related conditions.

Joint Providership


Financial Support


Access Period

You will have access to this learning activity for a period of six months after you enroll, or whenever the activity's CE credits expire (whichever comes first).

Originally presented on: 12/10/2022
Expiration date: 4/1/2024

ADCES CBs and LNGs: Please contact us at [email protected] to order a recorded webinar for a group viewing.


Celia A. Levesque, MSN, APRN, NP-C, CNS-BC, BC-ADM, CDE
Advanced Practice Nurse
MD Anderson Cancer Center

Faculty Disclosures

In accordance with Joint Accreditation criteria and the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education, the Association of Diabetes Care & Education Specialists (ADCES) must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any ineligible companies for the past 24 months.

Joint Accreditation/ACCME also requires that ADCES mitigate any reported conflict and eliminate the potential for bias during the educational activity. The disclosure information is intended to identify any ineligible relationships and allow learners to form their own judgments. However, if you perceive a bias during an activity, please report it on the evaluation.

Relevant disclosures (or lack thereof) among educational activity planners and faculty are as follows:


Celia A. Levesque, MSN, APRN, NP-C, CNS-BC, BC-ADM, CDE, – No conflicts of interest to report


Amy Butts, PA, BC-ADM, CDCES: Provention Bio, Xeris Pharmaceuticals, Novo Nordisk, Bayer Pharmaceuticals-Consultant; Novo Nordisk, Xeris Pharmaceuticals-Speaker’s bureau

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP (Conference Co-Chair): Abbott: Speaker/Honoraria (Ongoing); CeQur: Speaker/Honoraria (Ongoing); Dexcom: Speaker/Honoraria (Ongoing); Eli Lilly: Consultant (Ongoing); Insulet: Speaker/Honoraria (Ongoing); Lifescan: Consultant (Ongoing); Medtronic: Consultant (Ongoing), Speaker/Honoraria (Ongoing); Novo Nordisk: Speaker/Honoraria (Ongoing); Sanofi: Consultant (Ongoing)

Lucia Novak, MSN, ANP-BC, BC-ADM: Abbott Diabetes Care, Novo Nordisk, Xeris; Former: AstraZeneca; Janssen- Speakers Bureau; Novo Nordisk, Xeris, Sanofi, Proventio Bio-Consultant

Jennifer Okemah, MS, RD, BC-ADM, CDCES: Bigfoot Biomedical-Speakers Bureau; Medtronic, Tandem, Insulet, Dexcom, Mannkind- Consultant

Sean Oser, MD, MPH Abbott Diabetes: Research Grant (Ongoing); Dexcom: Consultant (Ongoing); MedScape: Consultant (Ongoing)

Tamara Oser, MD, MPH: Abbott Diabetes: Research Grant (Ongoing); Dexcom: Advisor Council (Terminated); MedScape: Consultant (Ongoing)

Angela Thompson, DNP, APRN, FNP-C, BC-ADM, CDCES. FAANP: Novo Nordisk: Focus
Group (Terminated, November 2, 2022)

Paulina Duker, MPH, RN, CDCES

Leslie Kolb, DrPH, MBA, BSN, RN

Cecelia Levesque, APRN, BC-ADM, CDCES, CNS, NP, RN

Elba Lopez, MEd, RDN, CDCES, BC-ADM

Gary Schreiner MS, CDCES (Conference Co-Chair),

Hope Warshaw, MMSc, RD, CDCES, BC-ADM

Sara Wettergreeen, PharmD

Disclosure and Mitigation of Relevant Conflicts of Interest

All identified relevant conflicts of interest have been mitigated.

The approval of this educational offering by the ADCES does not imply endorsement of specific therapies, treatments, or products discussed in the presentations.

Members: Free
Non-Members: Free

Knowledge: 0.75

Association of Diabetes Care & Education Specialists

Contact Us